Fresh Tracks Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.409; its P/E ratio is -0.65; Fresh Tracks Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	$ 7.94M	$ 53.00K	$ 9.00K	$ 2.05M
Gross Profit	-	$ 7.94M	$ 53.00K	$ 9.00K	$ 2.05M
EBIT	$ -1.04M	$ 1.91M	$ -2.28M	$ -4.27M	$ -4.59M
EBITDA	$ -1.03M	$ 1.92M	$ -2.27M	$ -4.26M	$ -4.58M
Net Income Common Stockholders	$ -1.04M	$ 1.91M	$ -2.28M	$ -4.28M	$ -4.53M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 10.90M	$ 12.00M	$ 8.90M	$ 10.80M	$ 8.70M
Total Assets	$ 11.59M	$ 13.06M	$ 9.79M	$ 11.97M	$ 10.27M
Total Debt	$ 0.00	$ 0.00	$ 19.00K	$ 28.00K	$ 49.00K
Net Debt	$ -10.90M	$ -12.00M	$ -8.88M	$ -10.77M	$ -8.65M
Total Liabilities	$ 1.66M	$ 2.11M	$ 1.85M	$ 2.10M	$ 3.08M
Stockholders Equity	$ 9.93M	$ 10.95M	$ 8.02M	$ 9.87M	$ 7.19M
Cash Flow	-
Free Cash Flow	$ -1.10M	$ 3.14M	$ -1.83M	$ -4.51M	$ -2.50M
Operating Cash Flow	$ -1.10M	$ 3.14M	$ -1.83M	$ -4.51M	$ -2.50M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -28.00K	$ -10.00K	-	$ 6.57M	$ 8.00K

Currency in USD

Fresh Tracks Therapeutics Earnings and Revenue History

Income Statement >

Fresh Tracks Therapeutics Debt to Assets

Balance Sheet >

Fresh Tracks Therapeutics Cash Flow

Cash Flow >

Fresh Tracks Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing